A Clinical Research Study for Type 2 Diabetes With Cardiovascular Disease

If you are living with type 2 diabetes, it’s time to talk about your increased risk of cardiovascular events.

Currently, the SURPASS-CVOT study is underway evaluating an investigational medication and its potential to prevent major adverse cardiovascular events in those with type 2 diabetes.

In Order to Qualify, You Must:

  • Be at least 40 years of age
  • Be diagnosed with type 2 diabetes
  • Have an established cardiovascular disease*

* coronary artery disease, cerebrovascular disease, or peripheral arterial disease

All those who participate will receive active medication. Either the investigational medication or dulaglutide (Trulicity) to compare reusults.

Health insurance is not required. All study-related care is provided at no cost.

Call 1-301-770-7373
or visit